Lucentis

Lucentis (Ranibizumab) is an intravitreal injection used to treat eye conditions. Learn about its uses, effects, and precautions for managing ocular health.

Lucentis is primarily used for the treatment of wet age-related macular degeneration (AMD), a condition that can lead to vision loss. It is also used for other eye conditions like diabetic macular edema and macular edema following retinal vein occlusion. Ranibizumab works by blocking a specific protein in the eye that can cause abnormal blood vessel growth and leakage.

Common effects of Lucentis may include eye pain, redness, and increased floaters. Some patients may experience temporary vision changes or discomfort following the injection. It is important to monitor for any persistent or severe side effects and consult a healthcare provider if they occur.

Lucentis should be administered by a healthcare professional experienced in intravitreal injections. Patients should inform their doctor about any eye infections or inflammation before treatment. Regular eye exams are recommended to monitor the condition and the effectiveness of the treatment.

Lucentis may interact with other medications, particularly those that affect the immune system or blood vessels. Patients should discuss all current medications with their healthcare provider to avoid potential interactions. Alcohol and certain supplements may also influence the effectiveness of the treatment.